Medico Remedies Limited (NSE:MEDICO)

Market Cap	4.15B
Revenue (ttm)	1.58B
Net Income (ttm)	103.33M
Shares Out	n/a
EPS (ttm)	1.25
PE Ratio	40.12
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	164,601
Average Volume	281,054
Open	49.37
Previous Close	50.45
Day's Range	49.10 - 51.98
52-Week Range	37.18 - 79.83
Beta	0.12
RSI	57.36
Earnings Date	Nov 14, 2025

About Medico Remedies

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and ster...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1994
• Employees: 213
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MEDICO

Financial Performance

In 2024, Medico Remedies's revenue was 1.51 billion, an increase of 4.15% compared to the previous year's 1.45 billion. Earnings were 100.93 million, an increase of 21.74%.